5.5 en Immune Response-2014

download 5.5 en Immune Response-2014

of 19

Transcript of 5.5 en Immune Response-2014

  • 8/19/2019 5.5 en Immune Response-2014

    1/50

    IMMUNE RESPONSE

    BiochemistryLecture 5.5

    Prof. Dalė Vieželienė 

    Department of Biochemistry

    E-mail: [email protected]

  • 8/19/2019 5.5 en Immune Response-2014

    2/50

    • Uses two basic strategies

    Humoral Immunity

    - works to eliminate antigens that are extracellular  

    Cellular Immunity

    - deals with antigens within host cell

    OVERVIEW OF ADAPTIVE IMMUNITY 

  • 8/19/2019 5.5 en Immune Response-2014

    3/50

    Humoral 

    Immunity

  • 8/19/2019 5.5 en Immune Response-2014

    4/50

    IMMUNOGLOBULINS Ig

    (ANTIBODIES)

    Glycoprotein molecules that are produced by plasma cells in

    response to an immunogen and which function as antibodies

    Receptors for antigen on B-cells When secreted –  immunoglobulin (antibodies)

    One B-cell makes only one kind of antibody

    Immunoglobulins comprise approx. 20 % proteins of blood

    plasma

  • 8/19/2019 5.5 en Immune Response-2014

    5/50

    • Antigen - any structure which el ici ts an immuneresponse  

    • Recognition is a central feature of the immuneresponse, required for detection  and elimination  ofdangerous organisms (pathogens)

    • This recognition is mediated by specific antigenreceptors which bind to structures (antigens) on, orderived from, pathogens.

    • Antigen receptors can be secreted  or cell-associated  

    Antigen recognition is mediated

    by specific antigen receptors

  • 8/19/2019 5.5 en Immune Response-2014

    6/50

    Antigenic determinant (epitope)

  • 8/19/2019 5.5 en Immune Response-2014

    7/50

    Structure of Immunoglobulins

    •2 identical Light chainsκ or λ   –  each about 220

    amino acids

    •2 identical Heavy chains -a d e g

    or  m -

    each about

    450 amino acids

    2 λ  + 2γ 

    •Disulfide bonds:• Inter-chain

    • Intra-chain

    Oligosaccharides

    CH1 

    VL 

    CL 

    VH 

    CH2 CH3 

    Hinge Region 

    Carbohydrate

    Disulfide bond

    •Variable & Constant Regions

    VL & CL

    VH & CH

    • Hinge Region

    •Domains (Domains are folded,compact, protease resistant

    structures) 

    VL & CLVH & CH1 - CH3 (or CH4)

  • 8/19/2019 5.5 en Immune Response-2014

    8/50

    A typical antibody molecule

    CHO CHO

    •Fab - fragment

    antigen binding  

    •Fc - fragment

    crystallisable  

    Fc –  effector

    functions. Fc

    interacts with

    innate effector

    mechanisms and

    greatly amplifiesthem

    Carbo-

    hydrate

    Fab

    Fc

    Immunoglobulins are

    Bifunctional Proteins

  • 8/19/2019 5.5 en Immune Response-2014

    9/50

    Pepsin cleavage sites - 1 x (Fab)2 & 1 x Fc

    Papain cleavage sites - 2 x Fab 1 x Fc

  • 8/19/2019 5.5 en Immune Response-2014

    10/50

    Antigens can bind in

    pockets or grooves or on

    extended surfaces in the

    binding site of antibodies

    by non-covalent forces

  • 8/19/2019 5.5 en Immune Response-2014

    11/50

  • 8/19/2019 5.5 en Immune Response-2014

    12/50

    Why do antibodies need an Fc region?

    • Detect antigen

    • Precipitate antigen

    • Block the active sites of toxins or pathogen-associated

    molecules

    • Block interactions between host and pathogen-associated

    molecules

    The (Fab)2

     fragment can:

    • Inflammatory and effector functions associated with cells

    • Inflammatory and effector functions of complement

    • The trafficking of antigens into the antigen processing

    pathways

    The Fc fragment can activate:

  • 8/19/2019 5.5 en Immune Response-2014

    13/50

    Consequences of antibody-antigen

    binding

    A. Viral Inhibition: virus preventing it from attaching to cellB. Neutralization: make toxins unable to bind to cellsC. Opsonization: antibodies bind to antigen and facilitate

    attachment of phagocytic cells

    D. and E. Agglutination and Precipitation: antibodies bind toantigen and get them into clumps, then one big “mouthful”for phagocyte

    F. Phagocytosis: Fc portion of antibody encouragesphagocytosis

    Complement Activation: binding of antigen to antibody cantrigger one pathway of complement cascade 

  • 8/19/2019 5.5 en Immune Response-2014

    14/50

  • 8/19/2019 5.5 en Immune Response-2014

    15/50

    The complement system

    Interacting set of enzymes (proteases) that upon activation giverise to cascade of reactions culminating in the destruction of

    pathogens and infected cells

  • 8/19/2019 5.5 en Immune Response-2014

    16/50

  • 8/19/2019 5.5 en Immune Response-2014

    17/50

    Classes of immunoglobulins

    (depend on H chain)

  • 8/19/2019 5.5 en Immune Response-2014

    18/50

    • Classes: IgM, IgG, IgD, IgA, IgE

    • Subclasses - IgG1, IgG2, IgG3, IgG4

    ANTIBODY CLASSES AND SUBCLASSES

    (ISOTYPES)

    MONOMER PENTAMER MONOMER DIMER MONOMER

    MONOMER WHEN

    ACTING AS B-CELL

    RECEPTOR FOR ANTIGEN

  • 8/19/2019 5.5 en Immune Response-2014

    19/50

    IgG

    (Monomeric)

     –  Major serum Ig

     –  Major Ig in extravascular spaces –  70-80% of total serum

    antibody

     –  Half-life in serum –  23 days

     –  Placental transfer (IgG2) –  Fixes complement (IgG4)

     –  Binds to Fc receptors (IgG2, IgG4)

    • Phagocytes - opsonization

    IgG1, IgG2 and IgG4  IgG3 

  • 8/19/2019 5.5 en Immune Response-2014

    20/50

    The pentameric IgM molecule

    irst line of defence

    Extra domain (CH4)J chain

    First Ig made by fetus and B cells

    5-10% of total serum antibody

    Half-life in serum –  5 days

    Fixes complement

    Agglutinating Ig

    Binds to Fc receptors

    B cell surface Ig

  • 8/19/2019 5.5 en Immune Response-2014

    21/50

    Dimeric IgA- protection of the mucosa

    •Serum –  monomer

    •Secretions (sIgA) - major secretory Ig (Mucosal or Local Immunity)

    •10-15 % of total serum antibody (if mucous membranes and body secretions

    included, percentage is much higher)•Half-life in serum –  6 days

    Tears, saliva, gastric and pulmonary secretions

    Dimer: J chain; Secretory component

    Does not fix complement (unless aggregated)

    Binds to Fc receptors on some cells

  • 8/19/2019 5.5 en Immune Response-2014

    22/50

    IgD (Monomer) 

     – 0,2% of total serum antibody

     – Half-life in serum –  3 days

     – B cell surface Ig, blood, lymph

     – Does not bind complement, serum function

    not known

    I l b li St t

  • 8/19/2019 5.5 en Immune Response-2014

    23/50

    •Secreted antibody

    Neutralisation

    Arming/recruiting effector cells

    Complement fixation

    • Cell surface antigen receptor on B cells

    Allows B cells to sense their antigenic

    environment

    Connects extracellular space with intracellular

    signalling machinery

    Immunoglobulin Structure-

    Function Relationship

  • 8/19/2019 5.5 en Immune Response-2014

    24/50

    IgE (Monomer)

     – Extra domain CH4

     – Least common serum Ig

     – 0,002% of total serum antibody

     – Half-life in serum –  2 days

    • Binds to basophils and mast cells

     – Allergic reactions – Parasitic infections (Helminths)

    • Binds to Fc receptor on eosinophils

     – Does not fix complement

  • 8/19/2019 5.5 en Immune Response-2014

    25/50

    Diversity: Antibody diversity is

    generated by:

    Multiple genes encoding both VL and VH

    Segmental joining of additional DNA segments to form the

    mature VL and VH genes

    Addition of nucleotide bases during the joining event

    Random association of Heavy and Light chains (facilitated by

    the VC, CH1 disulfide bond)

    Somatic (body) mutation of mature heavy and light chain

    genes after antigen stimulation generate higher affinity

    antibodies

  • 8/19/2019 5.5 en Immune Response-2014

    26/50

    Variable domains in immunoglobulins are made

    by combinatorial joining of gene segments

  • 8/19/2019 5.5 en Immune Response-2014

    27/50

  • 8/19/2019 5.5 en Immune Response-2014

    28/50

    Immunoglobulins and Development:

    Fetal synthesis of IgM and IgA begin during the 5th month.

    Immature B-cells express IgM on surface. IgM is monomeric on

    surface.

    Mature B-cells express IgM and IgD on surface.

    Plasma cells can secrete IgM, IgG, IgA, IgE (all but IgD)

    Memory cells display IgG, IgA, IgE, alone or combined with

    IgM. These are usually higher affinity than the orginal B-cell

    clone because of affinity maturation via somatic cell mutation 

    Th i l b li f il f

  • 8/19/2019 5.5 en Immune Response-2014

    29/50

    The immunoglobulin superfamily of

    proteins

    • Variety of other proteinswhich exhibit amino acid

    sequence homology with Ig

    also contain Ig-like domains

    and are considered as

    members of the

    immunoglobulin superfamily

    • The genes that encode these

    proteins have evolved from a

    common ancestor gene coding

    for a single domain.

    • The structural hallmark of

    immunoglobulin structure is the

    existence of globular „domains with

    β-pleated sheet folding pattern.

  • 8/19/2019 5.5 en Immune Response-2014

    30/50

    The immunoglobulin superfamily of proteins

  • 8/19/2019 5.5 en Immune Response-2014

    31/50

    B Cell Antigen Receptor (BCR)

    Ig-β Ig-α Ig-α  Ig-β 

  • 8/19/2019 5.5 en Immune Response-2014

    32/50

  • 8/19/2019 5.5 en Immune Response-2014

    33/50

    B-cells and Antibody Response

    • B-cell receptor binds to antigen

    • One of two things happen:

     – B-cell needs confirmation by T-cell to begin

    responding

     – B-cell does not need confirmation by T-cell to

     begin responding

  • 8/19/2019 5.5 en Immune Response-2014

    34/50

    When B-cell does not need

    confirmation from T-cell• B-cell receptors bind epitopes

    • B-cells respond by proliferating, producing

    antibody and differentiating into memory B-cells

  • 8/19/2019 5.5 en Immune Response-2014

    35/50

    When B-cell needs confirmation from T-cell 

  • 8/19/2019 5.5 en Immune Response-2014

    36/50

  • 8/19/2019 5.5 en Immune Response-2014

    37/50

    CELLULAR  IMMUNITY

    Types of T cells (cellular immune

  • 8/19/2019 5.5 en Immune Response-2014

    38/50

    Types of T cells (cellular immune

    response)

    • Also called CD8 T cells

    • Once activated, induce apoptosis in

    “self” cells infected with virus; destroy

    cancerous host cells

    • Distinguish infected “self” cells, because

    these cells present peptides on surface in

    MHC class I molecule

    • Also called CD4 T-cells

    • Antigen presenting cells, present

    antigen to T-helper cells in MHCclass II

    • If recognize antigen presented as

    foreign, activate macrophages,

    release cytokines that recruit other

    cells of immune system, stimulate NK cells activate B cells

    T Cell Receptor (TCR)

  • 8/19/2019 5.5 en Immune Response-2014

    39/50

    TcR molecule resembles Fab and is monovalent

    T Cell Receptor (TCR) 

    The TCRs are

    transmembrane,

    insoluble proteins.

    Approximately 105 

    TcR molecules arepresent on the surface

    of a T cell.

    •Consists of an α and

    β chain, or a γ and δ

    chain.

    • In human majority of T cells express the αβ heterodimer;

    the remaining T cells (small percentage) express the γδ

    heterodimer (no αδ, or γβ T cells exist). 

    • Each chain has a variable (V) and a constant domain (C).

    TCR Structure

  • 8/19/2019 5.5 en Immune Response-2014

    40/50

    TCR Structure

    •The variable domains in both chains contain threehypervariable regions which are equivalent to CDRs present in

    Ab light and heavy chains.

    • Transmembrane domains of both chains contain positively

    charged amino acid residues

    • The most αβ TCRs interact with peptide antigens presented by

    MHC molecules.

    • Certain αβ T cells react with nonpeptide antigens

    (carbohydrate and lipids)

    • In contrast to αβ TCR, γδ TCR exhibits limited diversity • The γδ T cells react with antigen (e.g. phospholipid antigen of

    Mycobacter ium tuberculosis ) that is neither processed or

    presented in the context of a MHC molecule.

  • 8/19/2019 5.5 en Immune Response-2014

    41/50

    TCR αβ chain receptor gene

    rearrange similar to antibody genes

  • 8/19/2019 5.5 en Immune Response-2014

    42/50

    C i f TCR d BCR

  • 8/19/2019 5.5 en Immune Response-2014

    43/50

    Comparison of TCR and BCR

    (antibody)

    BCR  TCR  

    Ligand Any structure peptide & lipid

    Bind native ligand Yes No

    Ag processing  No Yes

    MHC restriction  No Yes

    Somatic mutation Yes No

    Affinity for ligand Low to very high Low

    Co-receptors  No Yes

    T ll i th ti l h it i

  • 8/19/2019 5.5 en Immune Response-2014

    44/50

    • T cells recognize the antigen only when it is

    presented by self-MHC molecule.

    •This phenomenon, called self -MHC

    restriction, differentiates recognition of

    antigen by T cells and B cells.The MHC is highly polymorphic from individual

    to individual

    Single receptorrecognizes

    an alteration in self-

    MHC molecules induced

    because of association

    with foreign antigen.

  • 8/19/2019 5.5 en Immune Response-2014

    45/50

  • 8/19/2019 5.5 en Immune Response-2014

    46/50

  • 8/19/2019 5.5 en Immune Response-2014

    47/50

    Class I molecules are expressed on the surfaces of virtually all

    nucleated cells at varying densities

    Class II molecules are more restricted to cells of the immune

    system, primarily B lymphocytes and monocytes.

    Class I molecules function at the effector phase of immunity by

     presenting antigens to CD8+ T cells, which generally have cytotoxic

    or suppressor function Class II molecules present antigenic fragments to the CD4+ inducer

    (or helper) T cells on antigen presenting cells such as macrophages

    MHC class I molecules present peptides derived from cytosolic

     proteins; the pathway is called the cytosolic or endogenous pathway 

    MHC class II molecules present peptides derived from extracellular

     proteins; the pathway is called the endocytic or exogenous pathway.

  • 8/19/2019 5.5 en Immune Response-2014

    48/50

    Epitopes recognized by TCR does not

    need to lie on the surface of the protein

  • 8/19/2019 5.5 en Immune Response-2014

    49/50

  • 8/19/2019 5.5 en Immune Response-2014

    50/50

    Interplay between T-cells and B-cells